HealthThe Next Webabout 1 hour ago
bit.bio raises $25M Series D funding
2 min read
Cambridge-based biotech bit.bio raised $25M in a Series D round on Wednesday, ten months after securing its previous investment. Backed by M&G Investments and Dr Jonathan Milner, the company plans to expand its cell types and customer base rather than build new infrastructure. Demand for its products has grown significantly this year.
Level
Hype check
Tap to vote and see what everyone thinks.
